HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case with combined rare inborn metabolic disorders: congenital adrenal hyperplasia and ornithine transcarbamylase deficiency.

Abstract
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a common autosomal recessive disorder. Ornithine transcarbamylase (OTC) deficiency is the most common urea cycle disorder and demonstrates X-linked inheritance. In female OTC deficiency, phenotypes are variable according to X-inactivation patterns. These disorders develop separately, and their co-morbidity is extremely rare. We report one girl with CAH showing recurrent hyperammonemia and hepatitis after 2 years-of-age due to additional OTC deficiency.
AuthorsYoo-Mi Kim, Beom Hee Lee, Jin-Ho Choi, Gu-Hwan Kim, Han Hyuk Lim, Han-Wook Yoo
JournalGene (Gene) Vol. 527 Issue 1 Pg. 394-6 (Sep 15 2013) ISSN: 1879-0038 [Electronic] Netherlands
PMID23769969 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier B.V. All rights reserved.
Chemical References
  • CYP21A2 protein, human
  • Steroid 21-Hydroxylase
Topics
  • Adrenal Hyperplasia, Congenital (complications, diagnosis, genetics)
  • Base Sequence
  • Child, Preschool
  • DNA Mutational Analysis
  • Female
  • Heterozygote
  • Humans
  • Molecular Diagnostic Techniques
  • Molecular Sequence Data
  • Ornithine Carbamoyltransferase Deficiency Disease (complications, diagnosis, genetics)
  • Steroid 21-Hydroxylase (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: